Atlas Trials

Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients.

Clinical trial NCT05321862 · WITHDRAWN

Trial details

NCT number
NCT05321862
Sponsor
Nantes University Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-03-14
Primary completion
2023-05-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.